Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-03-22 1:6:7 pm | Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | GlobeNewsWire |
| 2024-02-22 5:0:0 am | Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses | GlobeNewswire |
| 2024-01-16 5:0:0 am | Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders | GlobeNewswire |
| 2024-01-03 5:30:0 am | Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals’ Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment | GlobeNewswire |
Please consider a small donation if you think this website provides you with relevant information